The debate about whether the NHS should use magic mushrooms to treat depression
Source
BBCThe debate about whether the NHS should use magic mushrooms to treat depressionbbc.co.ukYou might also wanna read

Synthetic Psilocybin Shows Strong Results in Treatment-Resistant Depression Trials
Compass Pathways, a British biotech company, announced strong results from two late-stage trials showing that a synthetic form of psilocybin
Real-World Study Shows Psilocybin Improves Treatment-Resistant Depression Symptoms
A real-world study of psilocybin therapy for treatment-resistant depression (TRD) in routine clinical practice shows clinically meaningful i
USC launches first clinical trial of psilocybin therapy for mental health treatment
USC researchers at the Keck School of Medicine, the Brain and Creativity Institute, and the USC Norris Comprehensive Cancer Center have laun
Psilocybin's Impact on Depression and Anxiety in Cancer Patients: Study Findings
A randomized double-blind trial studied the effects of psilocybin on 51 cancer patients with symptoms of depression and anxiety. Results sho
Psilocybin's Anti-Aging Effects Revealed in New Emory University Study
A new study suggests that psilocybin, the active ingredient in psychedelic mushrooms, may have anti-aging properties by extending cellular l
Severe Alzheimer's patient shows improved cognition and speech after psilocybin dose
A case report describes a woman with severe Alzheimer's disease who, after receiving a large dose of psilocybin, began initiating conversati
Severe Alzheimer's patient shows improved cognition and speech after psilocybin dose
A case report describes a woman with severe Alzheimer's disease who, after receiving a large dose of psilocybin, began initiating conversati

Comments
Sign in to join the conversation.
No comments yet. Be the first.